Publications by authors named "Tushar D Nichakawade"

Claim this Profile
T
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.
Jiaxin Ge, Joshua Urban, Sarah R DiNapoli, Bum Seok Lee, Taha Ahmedna, Tushar D Nichakawade

Nat Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.
Nour Sabiha Naji, Taha Ahmedna, J David Peske, Xinghan Zeng, Brandy Perkins, Tushar D Nichakawade

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.
Brian J Mog, Nikita Marcou, Sarah R DiNapoli, Alexander H Pearlman, Tushar D Nichakawade

Sci Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman

Nature· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors.
Adrian C Johnston, Gretchen M Alicea, Cameron C Lee, Payal V Patel, Eban A Hanna, Tushar D Nichakawade

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis